JMPWA
TCRT icon

JP Morgan Private Wealth Advisors’s Alaunos Therapeutics TCRT Stock Holding History

JP Morgan Private Wealth Advisors’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-86
Closed -$33K – 1737
2020
Q3 		$33K Buy
+86
New +$38K ﹤0.01% 1581

Other funds holding TCRT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
MVP
Miller Value Partners Sarasota, Florida $383M AUM 38.57% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

JP Morgan Private Wealth Advisors's TCRT Position: Q4 2020 in Review

JP Morgan Private Wealth Advisors sold out of Alaunos Therapeutics (TCRT) in Q4 2020, closing a stake of 86 shares — an estimated $33K sold.

JP Morgan Private Wealth Advisors first reported a position in TCRT in Q3 2020 and held it in 1 quarter. The position peaked at $33K in Q3 2020. 156 funds tracked by Wall St. Rank hold TCRT as of Q4 2020.

  • JP Morgan Private Wealth Advisors reported no remaining Alaunos Therapeutics position as of Q4 2020 after selling out during the quarter.
  • JP Morgan Private Wealth Advisors sold 86 Alaunos Therapeutics shares in Q4 2020, an estimated $33K.
  • JP Morgan Private Wealth Advisors first reported a position in Alaunos Therapeutics in Q3 2020 and held it in 1 quarter.
  • JP Morgan Private Wealth Advisors's Alaunos Therapeutics position peaked at $33K in Q3 2020.
  • 156 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2020.

Based on JP Morgan Private Wealth Advisors's 13F filing for Q4 2020, filed 16 Feb 2021.